Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 109
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03993847 | CLassification of Axial SpondyloarthritiS Inception Cohort | ||
| NCT02929745 | Single Cell Genomics of Psoriatic Skin | ||
| NCT07488156 | Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder | ||
| NCT00001018 | A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea | ||
| NCT05486481 | Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE) | ||
| NCT05619536 | Study of CD388 Subcutaneous Administration in Healthy Japanese Subjects | ||
| NCT00214552 | Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma. | ||
| NCT05629052 | TrEatment Approach in the Multimodal Era Registry | ||
| NCT01751451 | 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy | ||
| NCT05826756 | Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting | ||
| NCT03093272 | A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer | ||
| NCT02841033 | Daratumumab for the Treatment of Patients With AL Amyloidosis | ||
| NCT02938520 | Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants | ||
| NCT04394936 | An Explorative Psoriasis Biomarker Study | ||
| NCT05285137 | Study of CD388 Intramuscular or Subcutaneous Administration in Healthy Subjects | ||
| NCT03290950 | A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT04240210 | Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita) | ||
| NCT02772588 | AASUR in High Risk Prostate Cancer | ||
| NCT01837862 | A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas | ||
| NCT02756247 | A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma | ||
| NCT02438631 | Placental Passage and Disposition of Drugs: A Physiology-based Approach | ||
| NCT06232551 | Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism | ||
| NCT03063203 | Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia | ||
| NCT02422797 | Regimen Switch to Dolutegravir + Rilpivirine From Current Antiretroviral Regimen in Human Immunodeficiency Virus Type 1 Infected and Virologically Suppressed Adults (SWORD-2) | ||
| NCT02172872 | "InDACtion" vs "3+7" Induction in AML | ||
| NCT05971602 | Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis | ||
| NCT05117931 | A Study of Amivantamab in People With Esophagogastric Cancer | ||
| NCT02955810 | Cyclophosphamide-Bortezomib-Dexamethasone (CyBorD) With Daratumumab (DARA) | ||
| NCT00959894 | Evaluating Once Daily Etravirine in Treatment-Naive Adults With HIV Infection | ||
| NCT02987829 | Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients | ||
| NCT00006371 | A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer | ||
| NCT04399551 | A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries | ||
| NCT03696160 | The Late Presenter Treatment Optimisation Study | ||
| NCT00855413 | HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine | ||
| NCT02002130 | The Use of Glutamic Acid Decarboxylase (GAD) and Gamma-Amino Butyric Acid (GABA) in the Treatment of Type I Diabetes | ||
| NCT02800928 | Does CERC-501 Attenuate Stress-precipitated Smoking Lapse? | ||
| NCT05601973 | Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKI | ||
| NCT03397186 | Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma | ||
| NCT06549634 | Biomarkers of AKI in Patients Receiving Daratumumab | ||
| NCT04775550 | DARA RVD For High Risk SMM | ||
| NCT04407442 | Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab | ||
| NCT06066346 | A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy | ||
| NCT03899155 | Pan Tumor Rollover Study | ||
| NCT01947920 | A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers | ||
| NCT03450057 | Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment | ||
| NCT04667663 | CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. | ||
| NCT03655223 | Early Check: Expanded Screening in Newborns | ||
| NCT02471196 | Efficacy of ORM-12741 on Agitation/Aggression Symptoms in Alzheimer's Disease | ||
| NCT06856902 | BEhavioral and Adherence Model for Improving Quality, Health Outcomes and Cost-Effectiveness of healthcaRe | ||
| NCT03503344 | Apalutamide With or Without Stereotactic Body Radiation in Treating Castration-Resistant Prostate Cancer |
